India : Innovation and patents Sector Report_August 2013
Transcript of India : Innovation and patents Sector Report_August 2013
Source: Planning Commission, Aranca Research
Note: R&D - Research and Development
Seventh-largest R&D
investor
• In 2012, India had the world’s seventh-largest annual R&D investment, accounting for 2.8
per cent of global R&D expenditure; this is expected to increase to USD45.2 million by
2013, accounting for 3.0 per cent of global R&D spending
Pharma sector driving
R&D growth
• India’s pharmaceutical industry, which accounts for about 1.4 per cent of the global
pharmaceutical industry in value terms and 10 per cent in volume terms, is expected to
remain a major R&D growth driver
Rapidly growing
overseas investment • Cumulative overseas direct investments by India has expanded at a CAGR of 47.4 per
cent to USD146 billion during FY13 from USD21 billion in FY06
World’s sixth most
innovative country
• India stood sixth in terms of the most "innovative" country in General Electric's Annual
Global Innovation Barometer in January 2013
• The engineering sector is delicensed; 100 per cent FDI is allowed in the sector
• Due to policy support, there was cumulative FDI of USD14.0 billion into the sector over April 2000 – February 2012, making up 8.6 per cent of total FDI into the country in that period
Growing demand
Source: 2012 R&D spending estimate by Battelle, Automotive Research Association of India, Aranca Research
Notes: IPR - Intellectual Property Rights, CoE - Center of Excellence, PPP - Public Private Partnership, TRIPS - Trade Related Aspects of
Intellectual Property Rights, NMITLI - New Millennium Indian Technology Leadership Initiative, E - Estimate, NIC - National Innovation Council
Robust demand
• Rising income and evolving lifestyles have led to higher demand for aspirational products
• Indian companies’ investments in R&D is not surprising given the importance of innovation to sustain competitive edge
Attractive opportunities
• Vast opportunities in IT, pharmaceuticals, automobiles, biotechnology and agriculture
• India is the largest exporter of IT products and has the third largest pharma sector with a fast growing contract research segment
Policy support
• PPP for promoting exchange of scientific knowledge and R&D
• Strengthening educational infrastructure
• Amendments to the Patents Act (1970) to make it TRIPS-compliant
• Setting up of NIC in 2010
• Adoption of Science, Technology and Innovation Policy 2013
High ratings
• Establishment of CoEs in various areas; NMITLI initiative on PPP basis
• Increased investments by private players; setting up of R&D centers
• During FY07–13, IPR applications increased at a CAGR of 11.8 per cent from 137,900 to 269,500
2011
R&D
spending:
USD38
billion
2013E
R&D
spending:
USD45.2
billion
Advantage
India
Source: Korn/Ferry International, Asia-Pacific Research center, Stanford University, Aranca Research
Notes: TRIPS - Trade Related Aspects of Intellectual Property Rights, WTO - World Trade Organisation
• Indian Patents
and Designs Act
(1911)
• Dependence on
bulk imports
• Establishment
of CSIR, DRDO,
ICAR, ISRO and
IITs
• Patents Act (1970)
• Recognition of
process patents only
• Restricted foreign
ownership in Indian
companies
• Focus on ‘reverse
engineering’ among
pharmaceutical
companies
• TRIPS under WTO
(1995)
• Amendments to the
Patents Act (1970)
to make it TRIPS
compliant
• Reintroduction of
product patents
• Reduction in tariff
and non-tariff
measures
• Easing FDI norms
• Shifting focus in
pharma towards
clinical research
and new drug
development
Before 1970
Introductory Stage
1970 to early 1990s
Indigenisation
Stage
Early 1990s to 2005
Liberalisation and
Transition Era
2005 onwards
Growth Era
• Augmentation of network of
centrally-funded institutions
and universities
• Increase in R&D and exports
in sectors such as IT, pharma,
electronics and automobiles
• Innovations in automobiles
such as Nano, the world’s
least expensive car
• Focus on discovery of new
chemical entities by pharma
companies
• Numerous innovations from
rural India
• Setting up of National
Innovation Council
• Adoption of Science,
Technology and Innovation
Policy 2013
Source: Department of Industrial Policy
and Promotion, Aranca Research
Intellectual
Property (IP)
Patents
Trademarks
Geographical
Indications
Industrial Designs
Layout Designs
Plant Variety
Protection
Copyright
Source: Battelle, Aranca Research
Notes: GERD - Gross Domestic Expenditure on R&D,
R&D - Research and Development
Forecasted Expenditure of World’s Leading R&D
Investors in 2013 (USD Billion)
In 2012, India was the seventh-largest country in terms of
R&D investments, up from eighth largest in 2011
It is expected to retain this position in 2013, with R&D
investments increasing to USD45.2 billion from USD38
billion in 2011
32
39
42
45
51
58
91
162
220
424
Brazil
Russia
United Kingdom
India
France
South Korea
Germany
Japan
China
United States
Source: Battelle, Aranca Research
Notes: CAGR - Compound Annual Growth Rate;
PPP - Purchasing Power Parity, F - Forecast
R&D Spending in India (USD Billion) India’s share of global R&D spending rose to 2.8 per cent in
2012 from 2.6 per cent in 2010 and is forecasted to reach
3.0 per cent by 2013
India’s R&D investment growth is likely to outpace overall
GDP growth. During 2010–13, R&D spending (in terms of
PPP) is expected to expand at a CAGR of 11.6 per cent to
USD45.2 billion, while GDP (in terms of PPP) would
increase at a CAGR of 7.8 per cent
The Planning Commission of India expects to double the
government’s R&D spending from the current 0.9 per cent
of GDP to 2 per cent by 2017
33
38 40
45
0.80%
0.85%
0.85%
0.90%
0.75%
0.78%
0.81%
0.84%
0.87%
0.90%
0.93%
0
10
20
30
40
50
2010 2011 2012 2013F
R&D expenditure (PPP) AS a % of GDP -RHS
Source: Reserve Bank of India, Battelle, Aranca Research
Cumulative Overseas Direct Investment
(USD billion)
Cumulative overseas direct investments increased to
USD146 billion in FY13 from USD21 billion
This has led to significant amount of technology transfer
through industrial acquisitions
For instance, Tata Steel’s takeover of Corus brought with it
more than 80 patents and 1,000 researchers
21
38
56
100
125
146
FY08 FY09 FY10 FY11 FY12 FY13
Source: Department of Industrial Policy and Promotion
Aranca Research
Break-up of Intellectual Property Rights (IPR)
Applications (FY13)
During FY13, the total patent applications stood at 269.5
thousand
Trademark applications accounted for the largest share (79
per cent) of total applications at 212,900
Patent and design applications accounted for 17.6 per cent
(47,300 applications) and 3.4 per cent (9,200) share,
respectively
18%
3%
79%
Patent-LHS
Design -LHS
Trade markapplication -LHS
Source: Department of Industrial Policy and Promotion
Aranca Research
Intellectual Property (IP) applications (‘000) During FY07–13, intellectual property rights (IPR)
applications increased at a CAGR of 11.8 per cent from
137,900 to 269,500
Trademark applications expanded at a CAGR of 12.8 per
cent over FY07–13 to 212,900
Patent and design applications rose at a CAGR of 8.6 per
cent and 8.9 per cent, respectively, during the same period
Growing IP application activity indicates increased in-house
R&D and innovation in India 0
50
100
150
200
250
300
0
50
100
150
200
250
FY07 FY08 FY09 FY10 FY11 FY12 FY13
Patent-LHS Design -LHS
Trade mark application -LHS Total IPR applications -RHS
Source: Zinnov Consulting, The Indian R&D Landscape, 2012
Notes: CAGR - Compound Annual Growth Rate,
R&D - Research and Development,
MNC R&D Centers in India The number of MNC R&D centers in India has grown at a
CAGR of 16.4 per cent to 871
Around 30 per cent of the top 1,000 global R&D spending
organisations have centers in India
Most of the centers are located in metro cities – Bengaluru,
Delhi, Mumbai, Chennai and Hyderabad. However, MNCs
have begun spreading out to tier-2 cities after 2005
India’s robust talent pool of over 200,000 engineers has
grown at an average rate of 9 per cent over the last five
years; this has been supporting increased R&D activity
191
297
517
699
780
871
Pre 2000 2002 2004 2006 2008 2011
CAGR: 16.4%
Source: Zinnov Consulting, The Indian R&D Landscape, 2012
Notes: CAGR - Compound Annual Growth Rate,
R&D - Research and Development
MNC R&D centers Distribution in India (2012) Bengaluru (erstwhile Bengaluru) has 43 per cent of MNC
R&D centers, followed by Mumbai and Pune at 19 per cent
Until 2005, Tier-1 cities were the favourite destination for
MNCs due to the availability of rich talent, favourable
policies, and better quality of life
However, post-2005, MNCs have started expanding to Tier-
2 cities, as they offered benefits such as higher catchment
area, lower attrition, and cost arbitrage
Bengaluru 43%
Mumbai/ Pune 19%
Hyderabad 13%
NCR 11%
Chennai 10%
Others 4%
Source: Financial Express, Value Notes, Aranca Research,
Notes: R&D - Research and Development, IT - Information
Technology; CAGR - Compound Annual Growth Rate
R&D Outsourcing in India (USD Billion) R&D outsourcing has increased at a CAGR of 33.5 per cent
during 2003–11 to USD13.1 billion
Companies across sectors (such as IT, consumer
electronics, personal devices, medical electronics, telecom
and automobiles) are now offshoring complete product
responsibility
India has become one of the most preferred location for
engineering offshoring
By 2020, USD42 billion worth of work related to R&D of
product engineering is expected to be outsourced to India 1.3
13.1
2003 2011
CAGR: 33.5%
Source: Organisational websites, Aranca Research
Notes: R&D - Research and Development
Organisation Business description
Council of Scientific and Industrial Research (CSIR)
• CSIR is India’s largest R&D organisation, with 39 laboratories and 50 field stations. In FY12, CSIR had over
1,872 active patents in India, 813 in the US, 328 in the EU, 147 in Japan and 829 in other countries
• It is engaged in scientific industrial R&D for economic, environmental and societal benefits for the country
• Its research areas span across aerospace, biotechnology, chemicals, energy, foods, information
dissemination, leather and metals, minerals and manufacturing etc.
Defence Research and Development Organisation (DRDO)
• DRDO is engaged in design and development of weapon systems and equipment in accordance with the
requirements of the military services
• In 2012, DRDO had a network of 50 labs and establishments to carry out research. It has over 5,000 scientists
and about 25,000 other scientific, technical and supporting personnel
• Its research areas include aeronautics, armaments, combat vehicles, electronics, instrumentation engineering
systems, missiles, materials, naval systems, advanced computing, simulation and life sciences
Indian Council of Agricultural Research (ICAR)
• ICAR is one of the largest national agricultural organisations in the world. It consisted of 99 institutes and 53
agricultural universities across India in 2012
• It is the apex body for coordinating, guiding and managing research and education in agriculture, including
horticulture, fisheries and animal sciences in India
*This list is indicative
Organisation Business description
India Space Research Organisation (ISRO)
• ISRO is engaged in development of space technology and its application to various national tasks
• The organisation has 19 centers across India to pursue R&D activities
• Its research areas include communication satellites for television broadcast, telecommunications and
meteorological applications, and remote sensing satellites for management of natural resources
Indian Council of Medical Research (ICMR)
• ICMR is the apex body in India for the formulation, coordination and promotion of biomedical research and
one of the oldest medical research bodies in the world
• The council has a fleet of 21 institutes, six regional medical research centers and five units engaged in
medical research
• The council’s research priorities encompass the areas of communicable diseases, fertility control, maternal
and child health, nutritional disorders, and non-communicable diseases such as cancer, cardio-vascular
diseases, blindness and diabetes
Centre for Development of Advanced Computing (C-DAC)
• C-DAC is a premier R&D organisation of the Department of Information Technology (DIT)
• It is engaged in research in the areas of supercomputers, applied electronics, technology, applications and
health informatics.
• CDAC has filed 16 patent applications in FY11
Source: Organisational websites, Aranca Research
Notes: R&D - Research and Development *This list is indicative
Organisation Business description
Indian Institutes of Technology (IITs)
• It is a group of autonomous engineering and technology oriented institutes of higher education
• In FY11, IITs filed the highest number of patent applications amongst all the institutes and universities in India.
IIT Bombay filed 77 patent applications in 2011, an increase of 400 per cent from that in 2006
National Dairy Research Institute (NDRI)
• NDRI is engaged in research, teaching and extension activities in areas of dairy production, processing,
management and human resource development
• Its research activities focus on improving dairy productivity, innovating milk processing technologies and
disseminating information to the various stakeholders in dairy business to make dairying a self-sustaining
business
• In 2012, R&D activities comprised 71 in-house and 46 externally funded research projects, including 20 NAIP
projects in consortium mode with financial outlay of USD7.1 million
Indian Institute of Science (IISc)
• IISc is one of the earliest instances of PPP for a research institute in India
• It is engaged in research in various departments of science such as biological, chemical, electrical,
mathematical, physical and mechanical sciences
• In FY10, the institute filed the third highest number of patent applications amongst all the institutes and
universities in India
Source: Organisational websites, Aranca Research
Notes: R&D - Research and Development *This list is indicative
Organisation Business description
The Energy and Resources Institute (TERI)
• TERI is engaged in developing solutions to global problems in fields of energy, environment and sustainable
development
• The important research areas include biotechnology, earth science and climate change, technology
development, social transformation, and modelling and economic analysis
Institute of Life Sciences (ILS)
• ILS undertakes basic and translational research in frontier areas of life sciences
• The institute’s research interests are in the areas of infectious disease biology, gene function and regulation,
and translation research and technology development
Indian Institute for Advanced Studies (IIAS)
• IIAS is a residential centre for advanced research in humanities, social sciences and natural sciences
• Its major research areas include social, political and economic philosophy; comparative studies in philosophy
and religion; education, culture and arts; natural and life sciences; and national integration and nation building
Source: Organisational websites, Aranca Research
Notes: R&D - Research and Development
*This list is indicative
Organisation Business description
Hindustan Unilever Limited
• HUL is credited with innovations in product areas such as structured bar soap, fairness cream, zero alcohol
soap, poly-coated scouring bar for dishwashing, fortified salt, instant tea, critical components for a water
purifying device, and value-added (nature care) tea
• Worldwide, HUL has over 20,000 registered patents and patent applications
• The company filed 57 patent applications and was one of the top Indian patentees in FY11
Tata Steel Limited
• Tata Steel undertakes research in areas such as raw materials and coke, iron and ferro alloys, steel making,
coated products, materials characterisation and joining, materials modelling and product design, and
refractory technology
• The company filed 42 patents in FY12, taking its IP portfolio (filed and granted patents and copyrights) from 32
in FY2000 to 493
Cipla Limited
• Cipla’s R&D division focuses on new product development and new drug delivery systems across a range of
therapies
• In FY12, the company’s total R&D spending stood at USD59.2 million, a growth** of 13.6 per cent from a year
ago
• In 2011, Cipla filed 260 patent applications across the globe of which 13 were filed in India
Source: Organisational websites, Aranca Research
Notes: R&D - Research and Development, Growth** - In terms of INR *This list is indicative
Reaper Windrower
Machine
• For easy and timely
harvesting of
soybean crop
• Prevents shattering
of soybean pods due
to non-availability of
labourers for
harvesting the crop
in time
Hand Operated Water
Lifting Pump
• For convenient
water-lifting at a
good discharge rate
and low cost
• The pump was built
in response to a
dearth of available
pumps that could be
afforded by small
farmers
Bamboo Lathe
Machine
• For stripping off the
outer covering of
bamboo to develop
a smooth surface for
making interior
decoration and utility
items
• Reduces the time
and labour required
to do the job
manually
Pedal Operated
Washing Machine
• For washing clothes
while exercising on
a pedal machine
• An affordable and
convenient way of
washing clothes in
rural India which
experiences
frequent power
shortages
Source: Rediff Business, Aranca Research
Source: Times of India, Economic Times, The Hindu, Defence Now
Notes: ICBM - Inter-Continental Ballistic Missile, DRDO - Defence Research & Development Organisation, HSL - Hindustan Shipyard Limited
INS Vikrant
• India Indigenous
Aircraft Carrier (IAC)
• Total displacement
of over 40,000
tonnes
• Being built by
Cochin Shipyard
Limited
• To be inducted by
2014-16
Agni-V missile
• Successfully test
fired in April 2012
• India joined an elite
group of nations
having ICBM
technology
• Indigenously
developed by DRDO
• To be inducted by
2014-15
Arihant Class
Submarines
• With its launch in
2009, India joined
an elite group of
nations having
nuclear-powered
submarines
• Developed by HSL
• To be commissioned
by 2012-13
Tejas
• Second supersonic
aircraft to be
developed
indigenously by
Hindustan
Aeronautics Limited
(HAL)
• To be inducted by
2015 at a cost of
USD103.1 million
Source: Battelle, Electronics for You, Organisational websites, Aranca Research
Notes: PPP - Public Private Partnership, R&D - Research and Development, NMITLI - New Millennium
Indian Technology Leadership Initiative, CoE - Centre of Excellence, NIC - National Innovation Council
Policy support
PPP in R&D
Strengthening educational
infrastructure
Amendments to the Patents Act &
Setting up of NIC
Inviting Resulting in
Growing Demand
Evolving consumer lifestyles
Liberalisation and increasing competition
Proximity to future
growth markets
Increasing Investments
Establishment of CoEs, NMITLI initiative
Providing support to global projects from
India
Increasing corporate R&D investments
Source: Aranca Research
R&D spending by top six pharma giant in FY12
(USD million)
India’s pharmaceutical market is highly fragmented, with
300 large and 18,000 mid-sized and small companies
The country’s pharma industry accounts for about 1.4 per
cent of the global pharma industry in value terms and 10 per
cent in volume terms
The healthcare sector in India is expected to reach USD100
billion by 2015 from the current USD65 billion
This would help drive R&D growth in India; the average
R&D expenditure by Indian pharma companies is close to 6
per cent of total revenues
In FY12, total R&D spending by top six pharma companies
was USD503.5 million
130 124
98
59
39 36
16
Dr.
Re
dd
y's
Lab
s Lup
in
Ran
ba
xy
Cip
la
Pir
am
al
Hea
lth
ca
re
Wo
ckha
rt
Orc
hid
Che
mic
als
PPP in R&D
• Exchange of scientific knowledge between research centers, national laboratories,
institutes of higher learning and the industry
• The Indian Government plans to involve the private sector in R&D mainly for sectors like
vaccines, drugs and pharmaceuticals, super computing, solar energy and electronic
hardware
• The government has shell out a USD1.1 billion public-private partnership fund to support
research and development in India
Funded Institutions and
Foreign Universities
• Increasing the number of Indian Institutes of Technology (IITs) to 16, establishing 3 new
Indian institute of Science Education and Research (IISER) and 30 central universities
• Foreign universities permitted to enter the higher education system in India by establishing
their own campuses or joint ventures with existing universities
Tax Incentives
• Government offers 200 per cent deduction for capital and revenue expenditure incurred by
manufacturing companies with in-house R&D
• Income tax exemption of 125 per cent to 175 per cent on donations made to universities,
colleges and other scientific associations
Source: Battelle, Electronics for You, Organisational websites, Aranca Research
Notes: PPP - Public Private Partnership
Patents Act • Amendments to the Patents Act, 1970 to make it TRIPS compliant
• Increased incentives to domestic firms to conduct R&D
• Increased likelihood of technology transfer from developed nations
National Innovation
Council (NIC)
• In 2010, NIC was set up to implement strategies for inclusive innovation in India and
prepare a roadmap for innovation over 2010-20
• Tasks of NIC include creating a framework to encourage innovation by central and state
governments, universities, R&D institutions and SMEs
Source: Battelle, Aranca Research
Notes: SMEs - Small and Medium Enterprises
Source: Aranca Research
Introduction of STI
Policy 2013
• In January 2013, the government of India introduced the Science, Technology and
Innovation (STI) policy 2013 at the centenary sessions of the Indian Science Congress
held at Kolkata
Vision of STI Policy • The STI policy is aimed at helping India become one of the top five global scientific
powers by 2020
Rising Involvement of
The Private Sector
• STI aims to boost innovation through research and development (R&D) led by the public-
private partnership (PPP) mode thereby increase the investments on research and
development (R&D) to 2 per cent of GDP by 2017 from current 1 per cent
Increase in Human
Resources
• The policy seeks to increase the number of full-time R&D personnel by 66 per cent over
2013–17 and expand the number of publications from the current 3.5 per cent of global
share to around 7 per cent by 2020
2013
• Jan 13: DuPont is planning to
double their R&D activities in India
• Jun 13: Huawei will be setting up
a new research and development
(R&D) centre in Bengaluru with an
investment of USD150 million
2012
• Mar 12: Aditya Birla Group
launches R&D centre at Navi
Mumbai, developed at a cost of
about USD52 million
• Apr 12: Maruti Suzuki announces
an investment of USD500 million
to set up an R&D facility at Rohtak
• Jun 25: Chinese equipment maker
Huawei will invest USD2 billion to
set up global R&D center
• Nov 23: General Electric will
invest USD60 million to expand its
R&D facility; its is expected to
develop 30 new products by 2015
Source: India Electronic News, Moneycontrol, CNBC, Economic Times, Appliancemagazine.com,
Business Standard, The Hindu, Company websites, Aranca Research
Notes: R&D - Research and Development
2011
• Apr 11: Hitachi to invest
USD400 million to set up
R&D center in Bengaluru
• May 11: ISRO announces
setting up of spacecraft
R&D center on 530 acres
land at Chitradurga
• Oct 11: Saab AB and
Mahindra Satyam open an
R&D center in Hyderabad
for conducting research in
aerospace, defence and
civil security
2010
• Jan 10: Huawei allocates
USD500 million investment
for R&D center in
Bengaluru
• May 10: Bridgewater
opens center of Excellence
in Gurgaon for telecom
software R&D
• Aug 10: Alstom earmarks
USD39 million to establish
R&D center for power
products at the Infosys
campus
2009
• Jun 09: LG Electronics
doubles its annual R&D
investment outlay to
USD83 million
• Oct 09: Tata DoCoMo sets
up R&D center for value-
added services (VAS) and
mobile applications
• Oct 09: Hyundai sets up
R&D center at Hyderabad
at an investment of USD25
million
Source: India Electronic News, Moneycontrol, CNBC, Economic Times, Appliancemagazine.com,
Business Standard, The Hindu, Company websites, Aranca Research
Notes: R&D - Research and Development
Source: India Electronic News, Moneycontrol, CNBC, Economic Times, Appliancemagazine.com,
Business Standard, The Hindu, Company websites, Aranca Research
Notes: R&D - Research and Development
Centers of Excellence
(CoEs)
• The government has set
up CoEs based on the
PPP model for technology
development and transfer,
scientific research, human
resource development and
economic outreach
• CoEs have been set up in
the areas of telecom,
wireless technology, bio-
informatics, lasers and
optoelectronic devices and
nano-electronics
NMITLI
• The programme identifies
areas for development
based on national
consultation and invites
best partners from
institutions, academia and
private sector to play a role
in the process
• NMITLI has initiated 60
largely networked projects
in diverse areas involving
85 industry partners and
280 R&D groups from
different institutions with
investment outlay of
USD114 million
Centrally Funded
Institutes
• The government proposes
to establish 8 new IITs, 3
IISERs, 10 NITs and 20
IIITs by 2012
• These institutes together
account for over 80 per
cent of the total PhDs in
engineering in India
• The institutes are also
amongst the top Indian
applicants for patents from
the ‘institutes and
universities’ category
Central and Foreign
Universities
• Government is expected to
have set up 30 new central
universities by 2012
• New universities in 16
uncovered states
• The remaining 14 new
Central Universities will be
set up as world class
centers of excellence at
different locations
• Foreign universities
permitted can enter higher
education system in India
by having their own
campuses or joint ventures
with existing universities
Source: Lupin website
Note: API - Active Pharmaceutical Ingredient, CNS - Central Nervous
System, NSAIDS - Non-Steroidal Anti-Inflammatory Drugs, TB -
Tuberculosis, NCE - New Chemical Entity
Patents filed by Lupin Lupin is a renowned pharma player having a wide range of
quality, affordable generic and branded formulations and
APIs
Lupin has emerged as the fifth largest and among the top
five fastest-growing companies in the US
It is one of the world’s largest manufacturers of TB drugs
and has significant market share in the cardiovascular,
diabetology, asthma, paediatrics, CNS, Anti-infectives and
NSAIDs therapy segments
By FY12, Lupin’s total patent filing reached 1,024 up from
600 in FY08
38
26
75
42
26
84
42
12
5
14 17
43
FY09 FY10 FY11 FY12
Formulation Patents API/Process patents NCE patents
Source: Lupin website
Note: CAGR - Compound Annual Growth Rate
CAGR* - Growth in INR terms
Lupin net sales (USD million) Its revenues increased from USD822.5 million in FY09 to
USD1.7 million in FY13, at a CAGR* of 25.8 per cent
Advanced market formulations comprised nearly 52 per cent
of its revenues in FY12
822
1,007
1,271
1,474
1,742
FY09 FY10 FY11 FY12 FY13
CAGR*: 25.8%
Source: Office of the Controller General of Patents,
Designs and Trademarks 2009–10 Annual Report,
Company Annual Reports, Aranca Research
Indian IT Patent Applications (FY10) Infosys filed the highest number of patent applications in the
Indian IT sector, followed by LG Soft India and C-DAC
Research activity for different areas is allocated amongst
dedicated labs such as Software Engineering lab,
Convergence lab, Security and Privacy lab, Distributed
Computing lab and E-Com lab
6
6
6
7
23
SamsungIndia
Newgen
C-DAC
LG Soft India
Infosys
Source: Company Annual Reports, Aranca Research:
Note: CAGR - Compound Annual Growth Rate,
* CAGR calculated on rupee numbers
Income and net profit (USD billion) During FY06–13, the company’s revenues increased at a
CAGR* of 19.3 per cent to USD7.4 billion from USD2.2
billion
During the same period, net profit expanded at a CAGR of
17.8 per cent to USD1.7 billion from USD552 million
Infosys spent USD167 million in R&D expenses, up 80 per
cent from the USD92 million spent in FY10
Consequently, total R&D spending during FY13 came in at
2.3 per cent of total revenue
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
0
1
2
3
4
5
6
7
8
FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13
Source: Economic Times, Company Annual Reports,
Aranca Research
Note: CAGR: Compound Annual Growth rate, * CAGR calculated in
Indian Rupee terms
Strong Research and Development Incorporated in 1933, HUL is India’s leading company by
sales in the fast-moving consumer goods (FMCG) sector in
India. British-Dutch company Unilever owns a majority stake
of 52 per cent in HUL
In 2012, Forbes recognised HUL as the world's sixth most
innovative company; it was the highest ranked FMCG
company in the list
Eighteen of HUL’s brands featured in the ‘100 Most Trusted
Brands’ 2012 survey carried out by Brand Equity
HUL was felicitated for receiving the highest number of
patents in 2009 at the Annual Intellectual Property Awards
2010
The company has over 20,000 registered patents and
patent applications worldwide
891 994
1,612
FY10 FY11 FY12
CAGR*: 34.5%
Source: Company Annual Reports, Aranca Research
Notes: FY09* represents data for 15 months (Jan 2008- march
2009) as the company changed it reporting period from calendar
year to Fiscal year,
CAGR* - Compound Annual Growth Rate;
CAGR is calculated in INR
Sales (USD billion) During FY05–13, HUL’s revenues increased at a CAGR* of
12.0 per cent to USD4.9 billion from USD2.6 billion
During FY12, the company spent USD336 million in R&D,
up 62 per cent from the USD218 million spent in FY11
2.6 2.9
3.7
4.7
3.8
4.5 4.8 4.9
2005 2006 2007 FY09* FY10 FY11 FY12 FY13
CAGR*: 12.0%
Source: Company Annual Reports, Aranca Research
Note: CAGR* - Compound Annual Growth Rate
Total Application for Patents, Design and
Copyrights Filed
Tata Motors, a subsidiary of the Tata Group, is one of the
leading automobile company and has presence in 129
countries across six continents
Tata Motors is the leading commercial vehicle manufacturer
and the third-largest passenger vehicle manufacturer in
India
It is also the world’s fourth-largest truck manufacturer by
volume
During FY06–12, the number of applications for patents,
design, and copyrights filed by the company expanded at a
CAGR* of 16.4 per cent to 212 in FY12
Tata Motors’ Tata Indica is India's first indigenously
developed passenger car
Tata Nano, a USD2,100 car, is an indigenous example of
India’s innovation in the automobile segment
43 34
254
314
272
182 212
FY06 FY07 FY08 FY09 FY10 FY11 FY12
CAGR*: 16.4%
Source: Company Annual Reports, Aranca Research
Notes: R&D - Research and Development, CAGR - Compound
Annual Growth Rate; CAGR is calculated in INR terms
Total Application for Patents, Design and
Copyrights Filed
During FY06–13, Tata Motors’ revenues increased at a
CAGR* of 31.8 per cent to USD34.8 billion from USD6.2
billion
The company’s R&D spend expanded at a CAGR of 16.4
per cent to USD323.1 million in FY12 from USD176.0
million in FY07
6
8 10
16
20
28
36 35
FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13
CAGR*: 31.8%
Source: ARAI, Business Standard, India Law Office, Aranca Research
Notes: IT - Information Technology, ARAI - Automotive Research
Association of India, NVH - Noise, Vibration and Harshness
Pharma and Healthcare
• Contract research is a fast growing segment in the Indian healthcare industry
• Indian pharmaceuticals market is anticipated to expand at a CAGR of 17.2 per cent over
2011-2016 to touch USD27.3 billion
• India’s huge population places it among the world’s largest markets for vaccines and
drugs
Information Technology
(IT)
• India is increasingly seen as a product development destination
• Companies are now offshoring complete product responsibility including complex services
like product management
Automobiles
• Research is being carried out by individual companies as well as industry associations
such as ARAI in various areas such as structural dynamics, safety, NVH and electronics
• India is the sixth largest auto market globally and is poised to become the third largest by
2020
Source: ARAI, Business Standard, India Law Office, Aranca Research
Notes: IT - Information Technology, ARAI - Automotive Research
Association of India, NVH - Noise, Vibration and Harshness
Biotechnology
• Protein and antibody production, and fabrication of diagnostic protein chips are promising
areas for investment
• Stem cell research, cell engineering and cell-based therapeutics are other areas, wherein
India will cash in its expertise
Agriculture
• India has the potential to become a major producer of transgenic rice and several
genetically modified (GM) or engineered vegetables
• Hybrid seeds, including GM seeds, represent new business opportunities in India based
on yield improvement
Automotive Research Association of India (ARAI) Survey No 102, Vetal Hill, Off Paud Road, Kothrud,
Pune - 411 038
Tel: 91-020 30231111
Fax: 91-020 25434190
E-mail: [email protected]
Website: www.araiindia.com
Indian Society for Clinical Research (ISCR) c/o Pfizer center, 5, Patel Estate, S.V.Road, Jogeshwari(West),
Mumbai-400 102
Tel: 91-022 26774140, 66932028
E-mail: [email protected]
Website: www.iscr.org
The South India Textile Research Association (SITRA) 13/37, Avanashi Road, Coimbatore - 641 014
Tel: 91-422 2574367, 6544188
Fax: 91-422 2571896
Email : [email protected]
Website: www.sitra.org.in
API: Active Pharmaceutical Ingredient
ARAI: Automotive Research Association of India
CAGR: Compound Annual Growth Rate
CoE: center of Excellence
DRDO: Defence Research and Development Organisation
FDI: Foreign Direct Investment
FY: Indian Financial year (April to March)
So FY10 implies April 2009 to March 2010
GDP: Gross Domestic Product
GERD: Gross Domestic Expenditure on Research and Development
HAL: Hindustan Aeronautics Limited
HSL: Hindustan Shipyard Limited
IAC: Indigenous Aircraft Carrier
ICBM: Intercontinental Ballistic Missile
IT: Information Technology
NMITLI: New Millennium Indian Technology Leadership Initiative
NVH: Noise Vibration and Harshness
PPP: Public Private Partnership
PPP: Purchasing Power Parity
R&D: Research and Development
TRIPS: Trade Related Aspects of Intellectual Property Rights
USD: US Dollar
WTO: World Trade Organisation
Wherever applicable, numbers have been rounded off to the nearest whole number
Year INR equivalent of one US$
2004-05 44.95
2005-06 44.28
2006-07 45.28
2007-08 40.24
2008-09 45.91
2009-10 47.41
2010-11 45.57
2011-12 47.94
2012-13 54.31
Exchange Rates (Fiscal Year)
Year INR equivalent of one US$
2005 45.55
2006 44.34
2007 39.45
2008 49.21
2009 46.76
2010 45.32
2011 45.64
2012 54.69
2013 54.45
Exchange Rates (Calendar Year)
Average for the year
India Brand Equity Foundation (“IBEF”) engaged Aranca to prepare this presentation and the same has been prepared
by Aranca in consultation with IBEF.
All rights reserved. All copyright in this presentation and related works is solely and exclusively owned by IBEF. The
same may not be reproduced, wholly or in part in any material form (including photocopying or storing it in any medium
by electronic means and whether or not transiently or incidentally to some other use of this presentation), modified or in
any manner communicated to any third party except with the written approval of IBEF.
This presentation is for information purposes only. While due care has been taken during the compilation of this
presentation to ensure that the information is accurate to the best of Aranca and IBEF’s knowledge and belief, the
content is not to be construed in any manner whatsoever as a substitute for professional advice.
Aranca and IBEF neither recommend nor endorse any specific products or services that may have been mentioned in
this presentation and nor do they assume any liability or responsibility for the outcome of decisions taken as a result of
any reliance placed on this presentation.
Neither Aranca nor IBEF shall be liable for any direct or indirect damages that may arise due to any act or omission on
the part of the user due to any reliance placed or guidance taken from any portion of this presentation.